Back to search

Sweden· SE-20180503000074

Biseltoc 2,13 mg/ml Oral lösning

A medicinal product containing pentoxyverine hydrogen citrate, registered in Sweden by Opella Healthcare France SAS.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedBiseltoc 2,13 mg/ml Oral lösningATC—REGISTER NO.SE-20180503000074PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Pentoxyverine Hydrogen Citrate
Manufacturer
Opella Healthcare France SAS
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20180503000074

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Pentoxyverine hydrogen citrate in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pentoxyverine hydrogen citrate products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Austria · Mucomat Hustenstiller
  • Belgium · Pentoxyverine Sanofi, Pentoxyvérine Sanofi
  • Germany · Pentoxyverin Al, Sedotussin Hustenstiller
  • Spain · Bisolvon Calmatos
  • Finland · Biseltoc
  • France · Clarix Adultes Édulcorée Au Maltitol Liquide, Clarix Enfants
  • Italy · Pentοssiverina Opella Healthcare
  • Luxembourg · Pentoxyvérine Sanofi
  • Norway · Biseltoc
  • Portugal · Bisoltussin
  • Slovakia · Stadatussin, Stadatussin Kvapky

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/00e00a2a-9077-4919-a929-0727a101d86a
GET /v1/drugs/00e00a2a-9077-4919-a929-0727a101d86a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL"
  ],
  "se_npl_id": "20180503000074",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20180503000074",
  "product_doc_link": "https://docetp.mpa.se/LMF/Biseltoc%20oral%20solution%20SmPC_09001bee811a0294.pdf"
}

See everything about pentoxyverine hydrogen citrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.